Clinical trial · Observational
Spatiotemporal Associations Between the COVID-19 Pandemic and Cancer Diagnoses in Bavaria
Evaluation of Spatiotemporal Associations Between the COVID-19 Pandemic and the Incidence of Cancer Diagnoses in Bavaria, Germany: A Registry-based Study (PanSCan)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The COVID-19 pandemic has placed a significant strain on healthcare systems worldwide and has also impacted the diagnosis and treatment of cancer. In Germany, there was a notable decline in cancer diagnoses during the pandemic, partly due to delays in early detection and limited access to medical treatments. This study examines how the number of cancer cases in Bavaria changed before and during the pandemic, taking various factors into account, such as the socioeconomic status of different regions, the age of affected individuals, and the severity of the pandemic in each region. We aim to determine whether certain regions or specific types of tumors experienced greater declines in diagnoses, particularly for cancers with regular screening programs. The study seeks to provide a better understanding of how different social and geographical conditions influenced cancer diagnoses during the pandemic. These insights could help improve future preparedness for health crises like the pandemic and ensure that cancer treatment continues to function effectively even in times of crisis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- Bavarian Cancer Registry Cohort (2018-2023)
- description
- The study cohort consists of all incident cancer cases diagnosed in individuals aged 18 years and older in Bavaria, Germany, between January 1, 2018, and December 31, 2023. Eligible cases were identified through the Bavarian Cancer Registry and include carcinoma in situ.
Primary outcomes (1)
- measure
- Newly diagnosed cancer cases
- timeFrame
- 2018 to 2023
- description
- Number of incident cancer cases per district and month in Bavaria, Germany
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All incident cancer cases among individuals aged 18 years and older, including carcinoma in situ, diagnosed between 2018 and 2023 within Bavaria and recorded in the Bavarian Cancer Registry. Exclusion Criteria: * Death Certificate Only (DCO) cases. as they lack essential clinical information and the recorded date of diagnosis is in most cases the date of death, leading to temporal distortions in incidence estimates.
References
Publications (0)
Data not yet available